Overexpression of GPR35 confers drug resistance in NSCLC cells by β-arrestin/Akt signaling
Wei Wang(China Pharmaceutical University), Xueshan Qiu(Chinese Academy of Medical Sciences & Peking Union Medical College)
Cited by 33
Related Papers
Overexpression of yes‐associated protein contributes to progression and poor prognosis of non‐small‐cell lung cancer
|Cancer Science|2010|340
Combination of Nanomaterials in Cell-Based Drug Delivery Systems for Cancer Treatment
|Pharmaceutics|2021|92
LncRNA HOXC-AS3 promotes non-small-cell lung cancer growth and metastasis through upregulation of YBX1
|Cell Death and Disease|2022|62